Scleroderma Completed Phase 3 Trials for Nitroglycerin (DB00727)

Also known as: Dermatosclerosis

IndicationStatusPhase
DBCOND0013449 (Scleroderma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00419419Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's PhenomenonTreatment